Special edition: Adult-onset monogenic diseases

ReCent Medical News

Image: CatHouseProduction - stock.adobe.com

The life insurance industry generally recognizes 13 so-called adult-onset monogenic diseases (a.k.a Mendelian disorders) that represent the most commonly seen genetic disorders that start in adulthood and are caused by a single mutated gene.

Hannover Re’s global medical expert network recently completed an underwriting review of all 13 conditions and will publish one issue per month from a series of short articles highlighting important medical underwriting information for each condition. So stay tuned for upcoming editions. Some of the articles are also available in Japanese and Spanish.

#1

Hereditary breast and ovarian cancer: BRCA1/2

Read the full article

#2

Hypertrophic obstructive cardiomyopathy

Read the full article

#3

Dilated cardiomyopathy

Read the full article

#4

Arrhythmogenic right ventricular cardiomyopathy

Read the full article

#5

Huntington’s disease

Read the full article

#6:

Polycystic kidney disease

Read the full article

#7:

Long QT syndrome

Read the full article

#8:

Early-onset Alzheimer's disease

Read the full article

#9:

Brugada syndrome

Read the full article

#10:

Myotonic dystrophy

Read the full article

#11:

Lynch syndrome

Read the full article

#12:

Marfan syndrome

Read the full article

#13:

Catecholaminergic polymorphic ventricular tachycardia

Read the full article

Stay up to date on all ReCent newsletters

Get in touch via LinkedIn
Subscribe to our notification service

If you need further information or would like to send us feedback, please feel free to get in touch.

Contact forms

*The information provided in this document does in no way whatsoever constitute legal, accounting, tax or other professional advice. While Hannover Rück SE has endeavoured to include in this document information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.

Hannover Rück SE © 2024

Imprint | Disclaimer | Data privacy | www.hannover-re.com